Internal Medicine, Gastroenterology · Rochester, NY
NPI
1306854682
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
2080 Clinton Ave South
Rochester, NY, 14618
Phone (585) 271-2800
Groups this clinician bills Medicare through
Medicare paid, 2024
$26K
322 services
Medicare patients, 2024
128
Average age 72
Drug cost, 2024
$535K
1,405 prescriptions
Company payments, 2025
$1,583
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael E Kader was code G0500 (moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito), 111 times for 93 patients. In total Michael E Kader billed 322 services in 22 codes, and Medicare paid $26K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-12-08.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G0500 Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 111 | 93 | $4.24 | $471 |
| 45385 Colonoscopy - Lesion Removal | Facility | 41 | 38 | $196.38 | $8,052 |
| 43239 Upper GI Endoscopy | Facility | 37 | 35 | $79.58 | $2,945 |
| 99214 Office E&M - Established | Office | 20 | 18 | $77.83 | $1,557 |
| 99213 Office E&M - Established | Office | 15 | 12 | $62.97 | $944 |
| G0500 Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Office | 15 | 14 | $40.62 | $609 |
| 45380 Lower GI Endoscopy - Other | Facility | 12 | 12 | $137.03 | $1,644 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 11 | 11 | $170.16 | $1,872 |
By year: 2022 $30K for 356 services; 2023 $33K for 396 services; 2024 $26K for 322 services.
Medicare prescription drug claims, 2024
In 2024, the drug Michael E Kader prescribed most often to Medicare patients was Sod Sulf-Potass Sulf-Mag Sulf (Sodium, Potassium,mag Sulfates), with 294 prescriptions and refills. In total Michael E Kader wrote 1,405 Medicare prescriptions that cost $535K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 294 | 294 | 281 | $18K |
| Omeprazole Generic | 283 | 555 | 86 | $3,904 |
| Pantoprazole Sodium Generic | 134 | 272 | 42 | $1,769 |
| Mesalamine Generic | 94 | 191 | 22 | $98K |
| Famotidine Generic | 88 | 167 | 20 | $953 |
| Sucralfate Generic | 66 | 116 | 24 | $1,341 |
| Lansoprazole Generic | 59 | 138 | 17 | $3,085 |
| Ursodiol Generic | 35 | 70 | Under 11 | $8,293 |
| Balsalazide Disodium Generic | 34 | 46 | Under 11 | $6,770 |
| Mesalamine Er Mesalamine | 29 | 37 | Under 11 | $6,354 |
| Venlafaxine Hcl Er Venlafaxine Hcl | 21 | 27 | Under 11 | $239 |
| Creon Lipase/Protease/Amylase | 19 | 19 | Under 11 | $43K |
| Fluticasone Propionate Hfa Fluticasone Propionate | 18 | 22 | Under 11 | $7,967 |
| Cholestyramine Cholestyramine (With Sugar) | 17 | 35 | Under 11 | $2,017 |
| Prochlorperazine Maleate Generic | 13 | 13 | Under 11 | $745 |
Brand drugs: 215 claims; generic drugs: 1,190 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael E Kader $1,583 ($1,583 in general payments such as food, travel and fees) from 18 companies. The largest payer was Abbvie Inc. with $295.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 18 | $295 |
| Regeneron Healthcare Solutions, Inc. REGN | 7 | $184 |
| Janssen Biotech, Inc. JNJ | 10 | $158 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 9 | $158 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 4 | $105 |
| Aimmune Therapeutics, Inc. | 4 | $101 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 5 | $90.95 |
| Ferring Pharmaceuticals Inc. | 3 | $82.56 |
| Pfizer Inc. PFE | 4 | $75.56 |
| Ardelyx, Inc. ARDX | 3 | $75.1 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.